Standards for clinical trials in male sexual dysfunction: erectile dysfunction and rapid ejaculation

Area of Science:

• Male Sexual Dysfunction Research
• Clinical Trial Methodology
• Urology and Sexual Medicine

Background:

• Effective therapies for sexual dysfunctions hinge on well-designed clinical protocols, rigorous study procedures, and precise data analysis.
• Establishing clear standards is crucial for advancing the development of safe and effective treatments.

Purpose of the Study:

• To establish state-of-the-art recommendations and guidelines for clinical trials in male sexual dysfunction.
• Focus on developing standards for erectile dysfunction and rapid ejaculation clinical trials.

Main Methods:

• An international consultation involving over 200 multidisciplinary experts from 60 countries.
• Recommendations developed over a 2-year period based on evidence-based literature, expert discussion, and public debate.
• A dedicated committee of six experts from four countries focused on male sexual dysfunction clinical trial standards.

Main Results:

• Drug development involves phased approaches: Phase 1 (safety, pharmacokinetics), Phase 2 (dose-ranging), and Phase 3 (efficacy, drug interactions, special populations).
• Clinical studies necessitate validated outcome assessment instruments and defined patient populations.
• Patient-reported outcomes (diaries, questionnaires) and biostatistical input (sample power, statistical models) are essential.

Conclusions:

• Further research is required to develop comprehensive standards for clinical trials and outcome assessments in erectile dysfunction and rapid ejaculation.
• Standardization is key to improving the reliability and validity of research in male sexual dysfunction.